How medical research is failing minorities
Minorities are getting the short end of the stick when it comes to medical research, and it may have a drastic impact on the health…
Minorities are getting the short end of the stick when it comes to medical research, and it may have a drastic impact on the health of Hispanics, Asians, African Americans and other minorities in the future.
SEE ALSO: Report confirms Hispanics still underrepresented in medical school
As the population of the United States becomes more diverse there is a need for medical research to be inclusive of all races and ethincities; however, of the 10,000 clinical trials funded by the National Institutes of Health since 1997, only about 150 have focused on a particular ethnic or minority population.
According to Julie Dang, director of the Asian American Network for Cancer Awareness, Research and Training, based at UC Davis, that’s less than 2 percent of all clinical trials.
“Right now a lot of medicines are made for Caucasians, Dang, who headed up a recent study in the field, told The Modesto Bee. We need a diverse group of people to participate in order to do better cancer research and make therapies work for everybody.
Why are fewer minorities taking part in clinical trials?
Part of the issue is a lack of understanding on the part of researchers. According to the UC Davis study, medical terminology is a major turn-off for certain ethnic and racial groups–particularly Asians and Hispanics. Even though an individual may be interested in participating in a clinical trial, overly scientific forms can be a confusing deterrent. For many, it’s simply easier to not participate rather than feel as if they are stepping into an unclear process.
“Medical words are very hard for me, said 61-year-old Japanese immigrant Yukie Hirsch. “I have wanted to help for a long time about cancer because I have so much experience with cancer in Japan and the United States, but the problem is my English is poor. I could not understand what the letter was saying or what they wanted. So I gave up.
Dang’s research indicates it’s not that Hispanics and other groups are unwilling to participate in research; when approached in the correct manner, minorities are often very willing to give samples or be a part of clinical study.
The participation of minorities in clinical trials is becoming a necessity. As more and more research targets chronic health conditions represented among specific populations, a more diverse group of study participants is needed to develop targeted treatment options.